Browse our anti-TECTA (TECTA) Antibodies

Human Tectorin alpha (TECTA) interaction partners

1. TECTA mutations were identified in 6.0% of mid-frequency sensorineural hearing loss cases; these mutations were more frequent in patients with shallow U-shaped audiograms than those with U-shaped audiograms, and in families which have the family histories compatible with autosomal dominant than those with the family histories compatible with sporadic or autosomal recessive.

2. Up to now, merely 7 loci have been linked to mid-frequency hearing loss. Only four genetic mid-frequency deafness genes, namely, DFNA10 (EYA4 (show EYA4 Antibodies)), DFNA8/12 (TECTA), DFNA13 (COL11A2 (show COL11A2 Antibodies)), DFNA44 (CCDC50 (show CCDC50 Antibodies)), have been reported to date. [review]

3. A novel homozygous variant (c.734G > A) was found in exon 5 of the TECTA gene in one family leading to a nonsense mutation causing autosomal recessive nonsyndromic hearing loss.

4. To our knowledge, this is the first reported TECTA mutation leading to the DFNB21 form of hearing impairment among Maghrebian individuals suffering from congenital hearing impairment

5. the present report suggest that the association of RWDD3 (show RWDD3 Antibodies) and TECTA with paclitaxel-induced peripheral neuropathy may have been a false positive signal

6. Whole-exome sequencing identifies a novel genotype-phenotype correlation in the entactin (show NID1 Antibodies) domain of the known deafness gene TECTA.

7. Identified the c.211delC mutation in the KCNQ4 (show KCNQ4 Antibodies) gene and the c.2967C>A (p.H989Q) mutation in the TECTA gene to be associated with high-frequency sensorineural hearing loss in a Japanese family.

8. A rare novel mutation in TECTA causes autosomal dominant nonsyndromic hearing loss in a Mongolian family.

9. Data indicate that sequencing of candidate gene TECTA (alpha-tectorin) revealed a heterozygous c.5945C>A substitution in exon 19, causing amino acid substitution of Ala to Asp (show ASIP Antibodies) at a conservative position 1982.

10. this study failed to replicate a GWAS reporting an association between the 2 SNPs rs2296308 in RWDD3 (show RWDD3 Antibodies) and rs1829 in the intron of TECTA and time to neuropathy in ovarian cancer patients treated with paclitaxel

Mouse (Murine) Tectorin alpha (TECTA) interaction partners

1. Alpha-tectorin and beta-tectorin (show TECTB Antibodies) crosslink type II collagen (show COL2A1 Antibodies) fibrils and connect the tectorial membrane to the spiral limbus.

2. Tecta mutant mice all exhibit an enhanced tendency to have audiogenic seizures in response to white noise stimuli.

3. CEACAM16 (show CEACAM16 Antibodies) can probably form higher order structures with other tectorial membrane proteins such as alpha-tectorin and beta-tectorin (show TECTB Antibodies) and influences the physical properties of the tectorial membrane

4. The morphology and mechanical properties of wild-type, heterozygous, and homozygous Tecta tecta membrane, were analysed.

5. In Tecta(Y)(1870C/+) mice, the tectorin content of the tectorial membrane was reduced, as was the content of glycoconjugates reacting with the lectin wheat germ agglutinin.

6. The Tecta (A349D/A349D) mouse reveals that missense mutations in Tecta can be recessive and lead to tectorial membrane detachment